Business Context and Reporting Period
This Form 8-K is a current report filed by Fluidigm Corporation (not Standard BioTools Inc.) on July 29, 2015. The filing details the results of the company's 2015 Annual Meeting of Stockholders held on the same date.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting results.
Material Changes and Voting Results
Approximately 92% of the 28,863,262 outstanding shares were represented at the meeting. The following matters were voted upon:
- Election of Class II Directors: John A. Young and Gerhard F. Burbach were elected. Both received over 24.7 million votes "For" with minimal votes withheld.
- Advisory Vote on Executive Compensation: Stockholders approved the compensation for named executive officers for the year ended December 31, 2014. The vote was approximately 98.8% in favor (24,750,077 For vs. 287,121 Against).
- Ratification of Auditors: The appointment of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2015, was ratified with overwhelming support (26,415,008 For vs. 190,807 Against).
Guidance, Outlook, and Risks
The filing does not contain management commentary on financial guidance, outlook, risks, contingencies, or unusual items. It notes that the board has determined to hold an annual advisory vote on executive compensation based on prior stockholder approval.
Important Facts for Investors to Verify
- Confirm the registrant name is Fluidigm Corporation, as the input metadata referenced Standard BioTools Inc.
- Verify the specific terms of the executive compensation approved in the advisory vote by reviewing the referenced proxy statement.
- Check subsequent filings for the financial performance of the fiscal year ending December 31, 2015, as this 8-K contains no financial data.